empty
31.05.2022 12:48 PM
Prospective purchase of Gilead Sciences Inc (GILD) shares

Global disadvantages and risks:

Gilead Sciences shares were under the strongest pressure until mid-March of this year. The decrease in the impact of the coronavirus pandemic played a role here, which stimulated a wide demand for shares of pharmaceutical companies. But it still has problems, though not so critical. The company has a high level of debt of $ 26.208 billion as of March 31, 2022, to the amount of equity of $ 19.915 billion, which corresponds to 131.6%. But it should also be noted that the company's debt is well covered by operating cash flow of 40.5% and is offset by EBIT coverage of 11.3 times. It is expected that by the end of this year, revenue will decrease to $ 24.574 billion, and net income will decrease to $ 4.227 billion. It is assumed that earnings per share (EPS) at the end of 2022 will decrease to $ 3.436. According to 12 analysts, the possible range of EPS is from $ 3.030 to $ 4.500. Gilead Sciences had a large one-time loss of $ 4.3 billion, which affected the results of the last fiscal year. The price/profit ratio (P/E) is 18.1x, which is higher than the industry average, where the average value of the indicator is 15.5x, and the US market is 15.5x.

Positive:

The company is currently profitable. Profit is projected to grow by an average of 8.4% per year over the next 3 years. Gilead Sciences' margin improved. No events of concern have been detected, it has no negative equity. The company's shares were not diluted. The company has a projected profit growth of 8.4% above the savings rate of 1.9%. It is assumed that the return on capital over the next 3 years will increase by 28.6% against the industry average, which is 22.5%. Gilead Sciences' short-term assets of $ 12.6 billion exceed its short-term liabilities of $ 8.6 billion.

Gilead Sciences may resume trials of injectable lenacapavir for the treatment of HIV infection, which is a positive for the company's shares.

Distribution of 28 analyst recommendations on the company's shares: 15 to hold; 11 to buy; 2 to actively buy. The overall rating of recommendations for the company 2.5 is shifted towards buy. The company's shares are noticeably undervalued.

Key financial indicators:

The market capitalization is $ 81.96 billion.

Revenue for the last 12 months (TTM) was $ 27.472 billion.

Net profit for the last 12 months (TTM) $ 4.515 billion.

PEG 12 months (TTM) 0.54

P/E 12 months (TTM) 18.10

EPS 12 months (TTM) 3.58

Free Cash Flow (FCF) of $ 9.953 billion.

Dividend per share (%) 4.51

Dividend per share ($) 2.92

Ex-dividend date - 14.06.2022

The next dividend payment date is 27.07 - 01.08.2022.

Technical picture:

The security is trading above the support level of 64.00 on the daily chart, remaining in a three-month upward trend. The price is above the middle line of the Bollinger indicator. The MACD indicator is growing. The Relative Strength Index (RSI) is above the 50% level and is turning up.

Trading recommendation.

The stock is trading above the 50 and 100 daily moving averages. The price is above the support level of 64.00. The company's shares are slightly declining on the premarket by 0.203 to 64.78 from Monday's closing level of 64.80 (+0.51%).

Likely target levels:

The 1st target is 66.70 (short-term target) from yesterday's closing price of 64.80 (expected yield of 2.84%).

The 2nd goal is 68.85 (expected yield of 5.88%).

Conclusions:

We believe that the Gilead Sciences stock has a good potential for recovery growth. The paper can grow to the 3rd target mark in the period from 1 to 3 months.

This image is no longer relevant

Pati Gani,
Analytical expert of InstaForex
© 2007-2025
Select timeframe
5
min
15
min
30
min
1
hour
4
hours
1
day
1
week
Earn on cryptocurrency rate changes with InstaForex
Download MetaTrader 4 and open your first trade
  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    JOIN CONTEST

Recommended Stories

Stock Market on May 30th: S&P 500 and NASDAQ Resume Decline

At the close of the latest regular session, U.S. stock indices posted modest gains. The S&P 500 rose by 0.40%, the Nasdaq 100 added 0.39%, and the Dow Jones Industrial

Jakub Novak 10:45 2025-05-30 UTC+2

US Market: Court overturns trump tariffs

S&P 500 Market overview on 29.05 A federal court in the US has struck down all of former President Trump's trade tariffs. Major US indices on Wednesday: Dow -0.6%, NASDAQ

Jozef Kovach 12:53 2025-05-29 UTC+2

Stock Market on May 29th: S&P 500 and Nasdaq Pause Their Rally

At the close of the most recent regular trading session, U.S. stock indices posted modest losses. The S&P 500 declined by 0.56%, the Nasdaq 100 fell by 0.71%

Jakub Novak 11:04 2025-05-29 UTC+2

Navigating dollar surge and tech turmoil: key entry points for traders

Volatility has returned to financial markets. The dollar staged a sharp rally, driving down the yen, euro, and Swiss franc, but beneath the surface lies a web of unsettling signals

Аlena Ivannitskaya 11:44 2025-05-28 UTC+2

Update on US stock market on May 28

S&P500 US stock market is showing buoyant growth Snapshot of major US stock indices on Tuesday: Dow Jones: +1.8% NASDAQ: +2.5% S&P 500: +2.1% S&P 500 at 5,921

Jozef Kovach 10:38 2025-05-28 UTC+2

Stock Market on May 28th: S&P 500 and NASDAQ Continue Their Rapid Rally

Following the most recent regular session, U.S. stock indices closed with strong gains. The S&P 500 rose by 2.00%, while the Nasdaq 100 added 2.47%. The Dow Jones Industrial Average

Jakub Novak 09:43 2025-05-28 UTC+2

S&P 500 Forecast for May 28, 2025

The U.S. stock index, the S&P 500, has completed the correction that began on May 20. A sign of its completion is the price breakout above the inner boundary

Laurie Bailey 05:08 2025-05-28 UTC+2

Domestic Demand and Attractive Prices

The wave structure on the 24-hour chart for the #SPX instrument is generally easy to interpret. The global five-wave pattern doesn't even fit within the terminal window at the smallest

Chin Zhao 11:56 2025-05-27 UTC+2

Stock Market Update for May 27th: S&P 500 and NASDAQ Still Have Growth Potential

Following the most recent regular session, U.S. stock indices closed lower. The S&P 500 fell by 0.67%, while the Nasdaq 100 lost 1.00%. The industrial Dow Jones dropped by 0.61%

Jakub Novak 11:08 2025-05-27 UTC+2

Update on US stock market on May 27. Market picking up steam

S&P500 Snapshot of key US stock indices on Monday: Dow: -0%, NASDAQ: -0%, S&P 500: -0%, S&P 500 at 5802, with a trading range of 5400–6200. On Monday, US index

Jozef Kovach 10:40 2025-05-27 UTC+2
Can't speak right now?
Ask your question in the chat.
Widget callback
 

Dear visitor,

Your IP address shows that you are currently located in the USA. If you are a resident of the United States, you are prohibited from using the services of InstaFintech Group including online trading, online transfers, deposit/withdrawal of funds, etc.

If you think you are seeing this message by mistake and your location is not the US, kindly proceed to the website. Otherwise, you must leave the website in order to comply with government restrictions.

Why does your IP address show your location as the USA?

  • - you are using a VPN provided by a hosting company based in the United States;
  • - your IP does not have proper WHOIS records;
  • - an error occurred in the WHOIS geolocation database.

Please confirm whether you are a US resident or not by clicking the relevant button below. If you choose the wrong option, being a US resident, you will not be able to open an account with InstaForex anyway.

We are sorry for any inconvenience caused by this message.